Tokio Marine Asset Management CO LTD Acadia Pharmaceuticals Inc Transaction History

Tokio Marine Asset Management CO LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$19.4 - $27.42 $847,779 - $1.2 Million	-43,700 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $69,768 - $96,543	-1,700 Reduced 3.74%	43,700 $2.34 Million
Q3 2020 Nov 09, 2020	SELL	$36.42 - $57.0 $21,852 - $34,200	-600 Reduced 1.3%	45,400 $1.87 Million
Q2 2020 Aug 07, 2020	BUY	$39.26 - $52.73 $19,630 - $26,365	500 Added 1.1%	46,000 $2.23 Million
Q3 2019 Oct 29, 2019	BUY	$22.22 - $44.01 $88,880 - $176,040	4,000 Added 9.64%	45,500 $1.64 Million

Q4 2017 Feb 05, 2018	BUY	$26.84 - $39.14 $1.11 Million - $1.62 Million	41,500	41,500 $1.25 Million

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.